Ying-Kiat Zee

Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib

Andrea Li Ann Wong, Joline S.J. Lim, Arvind Sinha et al. · Journal of Translational Medicine · 2015 · 76 citations · Full text

Medicine, Oncology, Pharmacology +16

Outcomes After Multiple Lines of Chemotherapy for Platinum-Resistant Epithelial Cancers of the Ovary, Peritoneum, and Fallopian Tube

Richard W. Griffiths, Ying-Kiat Zee, Saran Evans et al. · International Journal of Gynecological Cancer · 2010 · 69 citations

Medicine, Gynecology, Oncology +16

Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients

Ling-Zhi Wang, Jacqueline Ramı́rez, Winnie Yeo et al. · PLoS ONE · 2013 · 66 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Patient and disease characteristics, and outcome of treatment defaulters from the Singapore TB control unit--a one-year retrospective survey.

Cynthia Bin Eng Chee, Irving Charles Boudville, Siew Pang Chan et al. · PubMed · 2000 · 35 citations

Public Health, Infectious Disease Control, Preventive Medicine +11

Pharmacogenetics-Guided Phase I Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid Tumours

Ross A. Soo, Nicholas Syn, Soo Chin Lee et al. · Scientific Reports · 2016 · 17 citations · Full text

Medicine, Oncology, Pharmacology +16